Steve Warrington

Steve was the founding Medical Director of HMR in 1993. He’s accredited by the MHRA as PI for FIH studies and has been the principal investigator for numerous phase 1 trials. He is a Qualified Person (QP) to release batches of investigational medicinal products (IMP). He holds a licence for administration of radiolabelled medicines to man. In 2012, he was promoted to Chief Medical Adviser.

He qualified in physiology and medicine at Cambridge University. He trained in clinical pharmacology, internal medicine and in cardiology at St Bartholomew’s Hospital and was awarded an MD by Cambridge University, for research into non-invasive methods of testing cardiovascular medicines in healthy subjects. He’s a Fellow of the Royal College of Physicians and a Fellow of the Faculty of Pharmaceutical Medicine. He’s also an Honorary Senior Lecturer in Clinical Pharmacology, St Bartholomew’s Hospital, London.

During 1981–1993, he was Medical Director of a commercial clinical pharmacology unit linked to the Department of Clinical Pharmacology, St Bartholomew’s Hospital.

He’s served as a committee member of the Clinical and Industry Sections of the British Pharmacological Society and as a referee for various clinical pharmacology journals, and has authored more than 150 publications on general and specialist clinical pharmacology.